PlainRecalls
FDA Drug Low Class III Terminated

Myorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules containing 3 x 10 Prescription Packs, Rx Only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forest, IL 60045, NDC 61748-304-13

Reported: June 26, 2019 Initiated: June 7, 2019 #D-1392-2019

Product Description

Myorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules containing 3 x 10 Prescription Packs, Rx Only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forest, IL 60045, NDC 61748-304-13

Reason for Recall

Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.

Details

Recalling Firm
Akorn Inc
Units Affected
16,216 cartons
Distribution
Nationwide USA
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Myorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules containing 3 x 10 Prescription Packs, Rx Only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forest, IL 60045, NDC 61748-304-13. Recalled by Akorn Inc. Units affected: 16,216 cartons.
Why was this product recalled?
Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 26, 2019. Severity: Low. Recall number: D-1392-2019.